Loading…
Loading…
Sentiment · FY2026 Q3
| Analyst | Firm | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| Jash Patwa | JPMorgan | 16 | 6% |
| Rob Labick | CJS Securities | 14 | 7% |
| Bret Jordan | Jefferies | 11 | 9% |
| Craig Kennison | Robert W. Baird | 11 | 9% |
| Chris Bottiglieri | BNP Paribas | 10 | 20% |
| John Healy | Northcoast Research | 8 | 13% |
| Jeff Licht | Stephens | 7 | 0% |
| Firm | Analysts | Questions | ChallengePercentage of questions scored as challenging — where the analyst pushed back, pressed for specifics, or questioned management's assumptions. |
|---|---|---|---|
| JPMorgan | 1 | 16 | 6% |
| CJS Securities | 1 | 14 | 7% |
| Robert W. Baird | 2 | 12 | 8% |
| Jefferies | 1 |
| 11 |
| 9% |
| BNP Paribas | 1 | 10 | 20% |
| Northcoast Research | 1 | 8 | 13% |
| Stephens | 1 | 7 | 0% |
Revenue grew 2.1% to $1.24 billion as 4.6% ASP expansion more than offset a 2.4% decline in global unit volumes, reflecting ongoing consumer pullback on insurance coverage amid rising premiums. Total loss frequency continued its long-term ascent to 23.6% in calendar Q1 2026, while U.S. insurance ASPs hit a seasonally adjusted all-time record with international buyers contributing nearly half of auction proceeds. The international segment delivered 14.1% revenue growth led by the U.K., Germany, and Canada, and the company maintained exceptional financial strength with $5.5 billion in liquidity and no debt.
Demand | Competitive Dynamics | Innovation & R&D | Pricing | Macroeconomic | Capex Investment | Revenue Growth | Geographic Expansion | |
|---|---|---|---|---|---|---|---|---|
| 2025Q1 | 5 | 6 | 1 | 1 | 1 | 2 | 1 | |
| 2025Q2 | 2 | 5 | 2 | 1 | 2 | 2 | 4 | |
| 2025Q3 | 5 | 3 | 1 | 1 | 2 | |||
| 2025Q4 | 8 | 4 | 4 | 1 | 2 | |||
| 2026Q1 | 8 | 5 | 1 | 3 | 2 | 1 | 1 | |
| 2026Q2 | 6 | 5 | 2 | 1 | 2 | 1 | 1 | |
| 2026Q3 | 4 | 3 | 1 | 2 | 2 | 4 | 2 |
| '25Q1 | '25Q2 | '25Q3 | '25Q4 | '26Q1 | '26Q2 | '26Q3 | |
|---|---|---|---|---|---|---|---|
| Demand | 5 | 2 | 5 | 8 | 8 | 6 | 4 |
| Competitive Dynamics | 6 | 5 | 3 | 4 | 5 | 5 | 3 |
| Innovation & R&D | 1 | 2 | 4 | 1 | 2 | 1 | |
| Pricing | 1 | 1 | 1 | 1 | 3 | 1 | 2 |
| Macroeconomic | 1 | 1 | 2 | 2 | 2 | 2 | |
| Capex Investment | 2 | 2 | 2 | 1 | 1 | ||
| Revenue Growth | 2 | 1 | 1 | 4 | |||
| Geographic Expansion | 1 | 4 | 2 |
| Company | Score | Trend | Rev YoY |
|---|---|---|---|
CPRT Copart | 5 | +2.1% | |
| CVNA Carvana Co. | 8 | +52.0% |